ICTO 2027

Biography:

Dr. Rajvir Dahiya is an internationally recognized scientist and distinguished academic leader with over four decades of contributions to oncology, cancer genomics, molecular medicine, and precision oncology. He earned his Ph.D. from PGIMER, Chandigarh, completed postdoctoral training at the University of Chicago, and received his M.D. and D.Sc. from Kagoshima University and Osaka University, Japan, respectively. Dr. Dahiya joined UCSF in 1987 and became Director of the Urology Oncology Research Center in 1991. Following 34 years of distinguished service, he retired as Professor Emeritus and Director of the Urology Research Center. He has authored over 550 scientific publications, contributed to scholarly books, and holds multiple U.S. patents. As of 2026, his reported scientific achievements include over 38,795 citations, a D-index of 108, and an i10-index of 325, with a global medicine ranking of 5,690 (top 0.15%) and U.S. ranking of 3,003 (top 1%). His research has been associated with 99 reported NIH and VA funding awards. He has served for approximately 25 years as a scientific review chairman and expert reviewer for U.S. Department of Defense cancer research programs and nearly 30 years on NIH scientific review panels, including NCI and NIDDK. He also serves as an Associate Editor of Clinical Cancer Research. His distinguished career reflects a lasting commitment to scientific innovation, cancer research, academic leadership, and advancing precision oncology worldwide.